Sexually transmitted diseases: Difference between revisions
(Created page with " Disorder Clinical 1st line Alternative Partner In Pregnancy N. Gonorrhea Urethritis/ Cervicitis M: urethritis with d/c or simply dysuria;can be asymptomatic ...") |
No edit summary |
||
| Line 1: | Line 1: | ||
{| style="border: medium none; border-collapse: collapse" border="1" | |||
| style="border: 0.5pt solid windowtext; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Disorder | |||
| style="border-style: solid solid solid none; border-color: windowtext windowtext windowtext -moz-use-text-color; border-width: 0.5pt 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Clinical | |||
| style="border-style: solid solid solid none; border-color: windowtext windowtext windowtext -moz-use-text-color; border-width: 0.5pt 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
1<sup>st</sup> line | |||
| style="border-style: solid solid solid none; border-color: windowtext windowtext windowtext -moz-use-text-color; border-width: 0.5pt 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Alternative | |||
| style="border-style: solid solid solid none; border-color: windowtext windowtext windowtext -moz-use-text-color; border-width: 0.5pt 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
Partner | |||
| style="border-style: solid solid solid none; border-color: windowtext windowtext windowtext -moz-use-text-color; border-width: 0.5pt 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
In Pregnancy | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
''N. Gonorrhea'' | |||
Urethritis/ | |||
Cervicitis | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
M: urethritis with d/c or simply dysuria;can be asymptomatic | |||
F: purulent discharge; can be asymptomatic | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Ceftriaxone 125mg IM | |||
OR | |||
Cefixime (Suprax) 400mg po x1 | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Cipro 500po x 1 – not acceptable in MSM, travel, California, Hawaii | |||
OR | |||
Spectinomycin 2g IM x 1 OR | |||
Disorder | Azithromycin 2g po x 1 | ||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
Treat and abstinence x 7d after both treated | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
CTX 125mg IM x 1 | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
''N. Gonorrhea'' | |||
Conjunctivitis | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
2-5d after birth | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Erythromycin ophthalmic 0.5% x1 | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Tetracycline ophthalmic 1% x1 | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
''N. Gonorrhea'' | |||
Disseminated | |||
(DGI) | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Petechial, pustular acral skin lesions, | |||
Asymmetrical arthralgias, tenosynovitis, | |||
Septic arthritis | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
CTX 1g IM/IV q24 | |||
-continue x24-48h until improvement | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Cefotax 1g IV q8 | |||
Spectinomycin 2g IV q12 | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
''Chlamydia Trachomatis'' | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
M: urethritis with d/c or simply dysuria; can be asymptomatic | |||
F: purulent discharge or cervical bleeding; can be asymptomatic | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Azithromycin 1g po x1 | |||
OR | |||
Doxycycline 100mg po bid x 7d | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Erythromycin base 500mg po qid x 7d OR | |||
Oflox 300mg po bid x 7d | |||
OR | |||
Levoflox 500mg po qd x 7days | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
Treat and abstinence x 7d after both treated | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Azithromycin 1g po x1 or | |||
Amoxicillin 500mg po tid x 7d | |||
Or | |||
Erythro | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
''Chlamydia'' | |||
''Trachomatis'' | |||
Conjunctivitis | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
5-12d after birth; silver nitrate ophthalmic only rx gonorrhea | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Erythromycin base 50mg/kg/day PO / 4 doses x14days | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
''Chlamydia Trachomatis'' | |||
Pneumonia | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
1-3months; afebrile, staccato cough with diffuse infiltrates on CXR; peripheral eosinophilia | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Erythromycin base 50mg/kg/day po / 4 doses x14days | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
''Trichamonas vaginalis'' | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
White, thick discharge | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Metronidazole 2g po x 1 | |||
OR | |||
Tinidazole 2g po x 1 | |||
PLUS | |||
Azithro 1g po x 1 | |||
-intravag cream not recommended | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Metronidazole 500mg bid for 7days; 1-2g po qday x 7d if recurrence | |||
OR | |||
Topical clotrimazole for metronidazole allergy– not as effective | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
Metronidazole 2g po x 1 | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Rx only if symptomatic but rx partner | |||
1<sup>st</sup> trimester, Clotrimazole 100mg hs for 7days | |||
After 1<sup>st</sup> trimester,<span> </span> Metronidazole 2g po x 1 | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Bacterial Vaginosis | |||
''Lactobacillus'' | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
White, fishy discharge | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Metronidazole 500mg po bid for 7d | |||
OR | |||
0.75% Metronidazole gel (one full applicator 5g) intravaginal qd for 5d | |||
OR | |||
2% Clindamycin cream 5g qd for 5d | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Clindamycin 300mg po bid for 7d (recurrence) | |||
OR | |||
Clindamycin ovules 100mg intravaginally qhs x 3d | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
Exam for STD | |||
No rx if nl | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
1<sup>st</sup> trimester, metronidazole 250mg po tid x7d | |||
After 1<sup>st</sup> trimester, 500mg po bid for 7days or 250mg po tid x7d or Clinda 300mg po bid x 7d | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Candidiasis | |||
(''Candida albicans''<span style="font-style: normal">)</span> | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Cottage cheese; | |||
DM or immunocompromised | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Butoconazole 2% cream 5g intravaginally for 3d | |||
OR | |||
Butaconazole-sustained 2% intravag x1 | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Clotrimazole 1%<span> </span> 5g cream intravaginally for 7-14d (OTC) | |||
OR | |||
Clotrimazole 100mg intravag tablet x 7d | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
Candicidal cream if dermatitis present | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Avoid fluconazole and ketoconazole. | |||
Rx with cream for 7d | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Chancroid | |||
(''H. ducreyi''<span style="font-style: normal">)</span> | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Painful ulcers with suppurative LAD | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Azithromycin 1g PO x 1 | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
CTX 250mg IM x1 | |||
Cipro 500mg PO bid x 3days | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
See CDC | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
CTX | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Granuloma Inguinale<span> </span> (Donvanosis) | |||
''Klebsiella granulomatis'' | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Painless lesions without LAD | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Doxycycline 100mg PO BID x 3wks and until all lesions heald | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Aizthromycin 1g po q week | |||
Ciproflox 750mg PO bid x 3 weeks | |||
Bactrim DS 1tab PO BID x 3 wks | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
same | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Erythromycin base 500mg po qid x 3wks | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Lymphogranuloma Venereum (LGV) | |||
''C. trach'' <span style="font-style: normal">serovars L1-L3</span> | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Tender, unilateral LAD; can lead to proctitis, fistulas | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Doxycycline 100mg po bid x 3 weeks | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Erythromycin base 500mg po qid x 3wks | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
Treat within 60days of exposure with standard Chlamydia Rx | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Erythromycin base 500mg po qid x 3wks | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Chancre- | |||
Primary | |||
Syphilis | |||
(''T. pallidum''<span style="font-style: normal">)</span> | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Painless ulcer, chancre | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Benzathine Penicillin G 1.2million U IM x1 | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Doxycycline 100mg po bid x 14d | |||
Tetracycline 500mg po qid x 14d | |||
CTX 1g IM/IV x 8-10d | |||
Azithromycin 2g po x 1? | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
See CDC | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Penicillin; if allergic desensitize | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Secondary Syphilis | |||
(''T. pallidum''<span style="font-style: normal">)</span> | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Skin rash, mucocutaneous lesions, LAD | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
See CDC | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Latent Syphilis | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Seroreactivity without other evidence of disease | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
''Early''<span style="font-style: normal"><nowiki>: Benzathine Penicillin G 2.4 million U IM x1</nowiki></span> | |||
''Late''<span style="font-style: normal"><nowiki>: Benzathine Penicillin G 2.4million U IM qweek x 3</nowiki></span> | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Doxycycline 100mg po bid x 28d | |||
Tetracycline 500mg po qid x 28d | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
See CDC | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Tertiary Syphilis | |||
(''T. pallidum''<span style="font-style: normal">)</span> | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Cardiac (aortitis), ophtho (iritis, uveitis), gumma | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Benzathine<span> </span> Penicillin G 2.4million U IM qweek x 3 | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
See CDC | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Neurosyphilis | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Meningitis, syphilitic eye disease | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Aqueous crystalline penicillin G 18-24million units/d administered as 3-4million units IV q4h or continuous infusion x 10-14days | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Procaine penicillin 2.4million units IM qday + Probenecid 500mg po qid<span> </span> | |||
BOTH for 10-14d | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
HSV (1<sup>st</sup> episode) | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Vesilcular rash | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Acyclovir 400mg po TID x 7-10day | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Famciclovir 250mg po TID x 7-10d | |||
Valacyclovir 1g PO BID x 7-10d | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
HSV (suppressive) | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Acyclovir 400mg PO BID | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Famciclovir 250mg po BID | |||
Valacyclovir 500mg PO qday | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Epididymitis | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Pain, swelling, inflammation of the epididymis | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
CTX 250mg IM + Doxycyline 100mg po bid x 10d | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Oflox 300mg<span> </span> po bid x 10d + levoflox 500mg po qday x 10d | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Epididymorchitis | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Proctitis | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Inflammation of the rectum (distal 10-12cm) | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
CTX 125mg IM x1 + Doxy 100mg po bid x 7d | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
PID | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Sexually active, no other sources and: CMT OR uterine OR adnexal TTP | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Outpt: | |||
Ceftriaxone 250mg IM x1 | |||
OR | |||
Cefoxitin 2g IM in a single dose and probenecid 1g orally administered concurrently in single dose | |||
OR | |||
Other parenteral 3<sup>rd</sup> gen cephalosporin eg ceftizoxime or cefotaxime | |||
PLUS | |||
Doxy 100mg po bid x14d | |||
+/- | |||
Metronidazole 500mg po bid x 14d | |||
Parenteral: | |||
Cefotetan 2g IV q12h | |||
OR | |||
Cefoxitin 2g IV q6h | |||
PLUS | |||
Doxycyline 100mg IV or PO q12 | |||
(''similar bioavailability)'' | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Outpt: | |||
Oflox 400mg po bid x 14d | |||
OR | |||
Levofloxacin 500mg po qday x 14d | |||
+/- | |||
Metronidazole 500mg po bid x 14d | |||
Parenteral: | |||
Clinda 900mg IV q8h | |||
PLUS | |||
Gent load 2mgkg IV; maintenance 1.5mg/kg q8h; single daily dosing may be substituted | |||
Oflox 400mg IV q12h | |||
OR | |||
Levoflox 500mg IV qday | |||
+/- | |||
Metro 500mg IVq8h | |||
OR | |||
Unasyn 3g IV q6h | |||
PLUS | |||
Doxy 100mg IV or PO q12h | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Scabies | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Crusted rash, intertiginous areas | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Permethrin 5% cream applied to all areas of body from neck down and rinsed off after 8-14h | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Ivermectin 200mcg/kg PO, repeated in 2weeks | |||
Lindane (1%) 1 ounce of lotion of 30g of cream applied in thin layer all over from neck down x 8 hours then rinse | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|- | |||
| style="border-style: none solid solid; border-color: -moz-use-text-color windowtext windowtext; border-width: medium 0.5pt 0.5pt; padding: 0in 5.4pt; width: 81.9pt" width="82" valign="top" | | |||
Pediculosis Pubis | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
Puritic genitalia | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 2.25in" width="162" valign="top" | | |||
Permethrin 1% cream: apply to affected areas x 10mins then wash off | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 175.5pt" width="176" valign="top" | | |||
Malathion lotion 0.5% apply x 8-12h then rinse | |||
OR | |||
Ivermectin<span> </span> 250mcg/kg PO repeated in 2 weeks | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.25in" width="90" valign="top" | | |||
| style="border-style: none solid solid none; border-color: -moz-use-text-color windowtext windowtext -moz-use-text-color; border-width: medium 0.5pt 0.5pt medium; padding: 0in 5.4pt; width: 1.5in" width="108" valign="top" | | |||
|} | |||
<nowiki>*BV: in pregnancy, associated with premature rupture of membranes, chorioamnionitis, preterm birth, postpartum infxn</nowiki> | |||
†Test for HIV, syphilis | |||
DeBonis | |||
Adapted from CDC 2006 | |||
<br/>Disorder | |||
Clinical | |||
1st line | |||
Alternative | |||
Partner | |||
In Pregnancy | |||
<br/>N. Gonorrhea | |||
N. Gonorrhea | |||
Urethritis/ | Urethritis/ | ||
| Line 20: | Line 582: | ||
Cervicitis | Cervicitis | ||
M: urethritis with d/c or simply dysuria;can be asymptomatic | |||
F: purulent discharge; can be asymptomatic | F: purulent discharge; can be asymptomatic | ||
Ceftriaxone 125mg IM | |||
OR | OR | ||
| Line 30: | Line 592: | ||
Cefixime (Suprax) 400mg po x1 | Cefixime (Suprax) 400mg po x1 | ||
Cipro 500po x 1 – not acceptable in MSM, travel, California, Hawaii | |||
OR | OR | ||
| Line 40: | Line 602: | ||
Azithromycin 2g po x 1 | Azithromycin 2g po x 1 | ||
Treat and abstinence x 7d after both treated | |||
CTX 125mg IM x 1 | |||
<br/>N. Gonorrhea | |||
N. Gonorrhea | |||
Conjunctivitis | Conjunctivitis | ||
2-5d after birth | |||
Erythromycin ophthalmic 0.5% x1 | |||
Tetracycline ophthalmic 1% x1 | |||
N. Gonorrhea | |||
<br/>N. Gonorrhea | |||
Disseminated | Disseminated | ||
| Line 66: | Line 626: | ||
(DGI) | (DGI) | ||
Petechial, pustular acral skin lesions, | |||
Asymmetrical arthralgias, tenosynovitis, | Asymmetrical arthralgias, tenosynovitis, | ||
| Line 72: | Line 632: | ||
Septic arthritis | Septic arthritis | ||
CTX 1g IM/IV q24 | |||
-continue x24-48h until improvement | -continue x24-48h until improvement | ||
Cefotax 1g IV q8 | |||
Spectinomycin 2g IV q12 | Spectinomycin 2g IV q12 | ||
<br/>Chlamydia Trachomatis | |||
M: urethritis with d/c or simply dysuria; can be asymptomatic | |||
F: purulent discharge or cervical bleeding; can be asymptomatic | F: purulent discharge or cervical bleeding; can be asymptomatic | ||
Azithromycin 1g po x1 | |||
OR | OR | ||
| Line 97: | Line 656: | ||
Doxycycline 100mg po bid x 7d | Doxycycline 100mg po bid x 7d | ||
Erythromycin base 500mg po qid x 7d OR | |||
Oflox 300mg po bid x 7d | Oflox 300mg po bid x 7d | ||
| Line 105: | Line 664: | ||
Levoflox 500mg po qd x 7days | Levoflox 500mg po qd x 7days | ||
Treat and abstinence x 7d after both treated | |||
Azithromycin 1g po x1 or | |||
Amoxicillin 500mg po tid x 7d | Amoxicillin 500mg po tid x 7d | ||
| Line 115: | Line 674: | ||
Erythro | Erythro | ||
<br/>Chlamydia | |||
Chlamydia | |||
Trachomatis | Trachomatis | ||
| Line 122: | Line 680: | ||
Conjunctivitis | Conjunctivitis | ||
5-12d after birth; silver nitrate ophthalmic only rx gonorrhea | |||
Erythromycin base 50mg/kg/day PO / 4 doses x14days | |||
Chlamydia Trachomatis | |||
<br/>Chlamydia Trachomatis | |||
Pneumonia | Pneumonia | ||
1-3months; afebrile, staccato cough with diffuse infiltrates on CXR; peripheral eosinophilia | |||
Erythromycin base 50mg/kg/day po / 4 doses x14days | |||
<br/>Trichamonas vaginalis | |||
White, thick discharge | |||
Metronidazole 2g po x 1 | |||
OR | OR | ||
| Line 162: | Line 718: | ||
Azithro 1g po x 1 | Azithro 1g po x 1 | ||
-intravag cream not recommended | -intravag cream not recommended | ||
Metronidazole 500mg bid for 7days; 1-2g po qday x 7d if recurrence | |||
OR | OR | ||
| Line 172: | Line 728: | ||
Topical clotrimazole for metronidazole allergy– not as effective | Topical clotrimazole for metronidazole allergy– not as effective | ||
Metronidazole 2g po x 1 | |||
Rx only if symptomatic but rx partner | |||
1st trimester, Clotrimazole 100mg hs for 7days | 1st trimester, Clotrimazole 100mg hs for 7days | ||
After 1st trimester, | After 1st trimester, Metronidazole 2g po x 1 | ||
<br/>Bacterial Vaginosis | |||
Bacterial Vaginosis | |||
Lactobacillus | Lactobacillus | ||
White, fishy discharge | |||
Metronidazole 500mg po bid for 7d | |||
OR | OR | ||
| Line 197: | Line 752: | ||
2% Clindamycin cream 5g qd for 5d | 2% Clindamycin cream 5g qd for 5d | ||
Clindamycin 300mg po bid for 7d (recurrence) | |||
OR | OR | ||
| Line 203: | Line 758: | ||
Clindamycin ovules 100mg intravaginally qhs x 3d | Clindamycin ovules 100mg intravaginally qhs x 3d | ||
Exam for STD | |||
No rx if nl | No rx if nl | ||
1st trimester, metronidazole 250mg po tid x7d | |||
After 1st trimester, 500mg po bid for 7days or 250mg po tid x7d or Clinda 300mg po bid x 7d | After 1st trimester, 500mg po bid for 7days or 250mg po tid x7d or Clinda 300mg po bid x 7d | ||
<br/>Candidiasis | |||
Candidiasis | |||
(Candida albicans) | (Candida albicans) | ||
Cottage cheese; | |||
DM or immunocompromised | DM or immunocompromised | ||
Butoconazole 2% cream 5g intravaginally for 3d | |||
OR | OR | ||
| Line 228: | Line 782: | ||
Butaconazole-sustained 2% intravag x1 | Butaconazole-sustained 2% intravag x1 | ||
Clotrimazole 1% 5g cream intravaginally for 7-14d (OTC) | |||
OR | OR | ||
| Line 234: | Line 788: | ||
Clotrimazole 100mg intravag tablet x 7d | Clotrimazole 100mg intravag tablet x 7d | ||
Candicidal cream if dermatitis present | |||
Avoid fluconazole and ketoconazole. | |||
Rx with cream for 7d | Rx with cream for 7d | ||
Chancroid | <br/>Chancroid | ||
(H. ducreyi) | (H. ducreyi) | ||
Painful ulcers with suppurative LAD | |||
Azithromycin 1g PO x 1 | |||
CTX 250mg IM x1 | |||
Cipro 500mg PO bid x 3days | Cipro 500mg PO bid x 3days | ||
See CDC | |||
CTX | |||
<br/>Granuloma Inguinale (Donvanosis) | |||
Granuloma Inguinale | |||
Klebsiella granulomatis | Klebsiella granulomatis | ||
Painless lesions without LAD | |||
Doxycycline 100mg PO BID x 3wks and until all lesions heald | |||
Aizthromycin 1g po q week | |||
Ciproflox 750mg PO bid x 3 weeks | Ciproflox 750mg PO bid x 3 weeks | ||
| Line 276: | Line 828: | ||
Bactrim DS 1tab PO BID x 3 wks | Bactrim DS 1tab PO BID x 3 wks | ||
same | |||
Erythromycin base 500mg po qid x 3wks | |||
<br/>Lymphogranuloma Venereum (LGV) | |||
Lymphogranuloma Venereum (LGV) | |||
C. trach serovars L1-L3 | C. trach serovars L1-L3 | ||
Tender, unilateral LAD; can lead to proctitis, fistulas | |||
Doxycycline 100mg po bid x 3 weeks | |||
Erythromycin base 500mg po qid x 3wks | |||
Treat within 60days of exposure with standard Chlamydia Rx | |||
Erythromycin base 500mg po qid x 3wks | |||
<br/>Chancre- | |||
Chancre- | |||
Primary | Primary | ||
| Line 304: | Line 854: | ||
(T. pallidum) | (T. pallidum) | ||
Painless ulcer, chancre | |||
Benzathine Penicillin G 1.2million U IM x1 | |||
Doxycycline 100mg po bid x 14d | |||
Tetracycline 500mg po qid x 14d | Tetracycline 500mg po qid x 14d | ||
| Line 316: | Line 866: | ||
Azithromycin 2g po x 1? | Azithromycin 2g po x 1? | ||
See CDC | |||
Penicillin; if allergic desensitize | |||
<br/>Secondary Syphilis | |||
Secondary Syphilis | |||
(T. pallidum) | (T. pallidum) | ||
Skin rash, mucocutaneous lesions, LAD | |||
See CDC | |||
Latent Syphilis | |||
<br/>Latent Syphilis | |||
Seroreactivity without other evidence of disease | |||
Early: Benzathine Penicillin G 2.4 million U IM x1 | |||
Late: Benzathine Penicillin G 2.4million U IM qweek x 3 | Late: Benzathine Penicillin G 2.4million U IM qweek x 3 | ||
Doxycycline 100mg po bid x 28d | |||
Tetracycline 500mg po qid x 28d | Tetracycline 500mg po qid x 28d | ||
See CDC | |||
<br/>Tertiary Syphilis | |||
Tertiary Syphilis | |||
(T. pallidum) | (T. pallidum) | ||
Cardiac (aortitis), ophtho (iritis, uveitis), gumma | |||
Benzathine Penicillin G 2.4million U IM qweek x 3 | |||
See CDC | |||
<br/>Neurosyphilis | |||
Meningitis, syphilitic eye disease | |||
Aqueous crystalline penicillin G 18-24million units/d administered as 3-4million units IV q4h or continuous infusion x 10-14days | |||
Procaine penicillin 2.4million units IM qday + Probenecid 500mg po qid | |||
BOTH for 10-14d | BOTH for 10-14d | ||
<br/>HSV (1st episode) | |||
Vesilcular rash | |||
Acyclovir 400mg po TID x 7-10day | |||
Famciclovir 250mg po TID x 7-10d | |||
Valacyclovir 1g PO BID x 7-10d | Valacyclovir 1g PO BID x 7-10d | ||
<br/>HSV (suppressive) | |||
Acyclovir 400mg PO BID | |||
Famciclovir 250mg po BID | |||
Valacyclovir 500mg PO qday | Valacyclovir 500mg PO qday | ||
<br/>Epididymitis | |||
Pain, swelling, inflammation of the epididymis | |||
CTX 250mg IM + Doxycyline 100mg po bid x 10d | |||
Oflox 300mg po bid x 10d + levoflox 500mg po qday x 10d | |||
<br/>Epididymorchitis | |||
<br/>Proctitis | |||
Inflammation of the rectum (distal 10-12cm) | |||
CTX 125mg IM x1 + Doxy 100mg po bid x 7d | |||
<br/>PID | |||
PID | |||
Sexually active, no other sources and: CMT OR uterine OR adnexal TTP | |||
Outpt: | |||
Ceftriaxone 250mg IM x1 | Ceftriaxone 250mg IM x1 | ||
| Line 478: | Line 1,018: | ||
Metronidazole 500mg po bid x 14d | Metronidazole 500mg po bid x 14d | ||
Parenteral: | Parenteral: | ||
| Line 494: | Line 1,034: | ||
(similar bioavailability) | (similar bioavailability) | ||
Outpt: | |||
Oflox 400mg po bid x 14d | Oflox 400mg po bid x 14d | ||
| Line 508: | Line 1,048: | ||
Metronidazole 500mg po bid x 14d | Metronidazole 500mg po bid x 14d | ||
Parenteral: | Parenteral: | ||
| Line 518: | Line 1,058: | ||
Gent load 2mgkg IV; maintenance 1.5mg/kg q8h; single daily dosing may be substituted | Gent load 2mgkg IV; maintenance 1.5mg/kg q8h; single daily dosing may be substituted | ||
Oflox 400mg IV q12h | Oflox 400mg IV q12h | ||
| Line 538: | Line 1,078: | ||
Doxy 100mg IV or PO q12h | Doxy 100mg IV or PO q12h | ||
<br/>Scabies | |||
Crusted rash, intertiginous areas | |||
Permethrin 5% cream applied to all areas of body from neck down and rinsed off after 8-14h | |||
Ivermectin 200mcg/kg PO, repeated in 2weeks | |||
Lindane (1%) 1 ounce of lotion of 30g of cream applied in thin layer all over from neck down x 8 hours then rinse | Lindane (1%) 1 ounce of lotion of 30g of cream applied in thin layer all over from neck down x 8 hours then rinse | ||
<br/>Pediculosis Pubis | |||
Puritic genitalia | |||
Permethrin 1% cream: apply to affected areas x 10mins then wash off | |||
Malathion lotion 0.5% apply x 8-12h then rinse | |||
OR | OR | ||
Ivermectin | Ivermectin 250mcg/kg PO repeated in 2 weeks | ||
*BV: in pregnancy, associated with premature rupture of membranes, chorioamnionitis, preterm birth, postpartum infxn | *BV: in pregnancy, associated with premature rupture of membranes, chorioamnionitis, preterm birth, postpartum infxn | ||
†Test for HIV, syphilis | †Test for HIV, syphilis | ||
DeBonis | DeBonis | ||
| Line 587: | Line 1,126: | ||
Adapted from CDC 2006 | Adapted from CDC 2006 | ||
<br/>[[Category:ID]] | |||
[[Category:ID]] | |||
Revision as of 07:27, 12 March 2011
|
Disorder |
Clinical |
1st line |
Alternative |
Partner |
In Pregnancy |
|
N. Gonorrhea Urethritis/ Cervicitis |
M: urethritis with d/c or simply dysuria;can be asymptomatic F: purulent discharge; can be asymptomatic |
Ceftriaxone 125mg IM OR Cefixime (Suprax) 400mg po x1 |
Cipro 500po x 1 – not acceptable in MSM, travel, California, Hawaii OR Spectinomycin 2g IM x 1 OR Azithromycin 2g po x 1 |
Treat and abstinence x 7d after both treated |
CTX 125mg IM x 1 |
|
N. Gonorrhea Conjunctivitis |
2-5d after birth |
Erythromycin ophthalmic 0.5% x1 |
Tetracycline ophthalmic 1% x1 |
||
|
N. Gonorrhea Disseminated (DGI) |
Petechial, pustular acral skin lesions, Asymmetrical arthralgias, tenosynovitis, Septic arthritis |
CTX 1g IM/IV q24 -continue x24-48h until improvement |
Cefotax 1g IV q8 Spectinomycin 2g IV q12 |
||
|
Chlamydia Trachomatis |
M: urethritis with d/c or simply dysuria; can be asymptomatic F: purulent discharge or cervical bleeding; can be asymptomatic |
Azithromycin 1g po x1 OR Doxycycline 100mg po bid x 7d |
Erythromycin base 500mg po qid x 7d OR Oflox 300mg po bid x 7d OR Levoflox 500mg po qd x 7days |
Treat and abstinence x 7d after both treated |
Azithromycin 1g po x1 or Amoxicillin 500mg po tid x 7d Or Erythro |
|
Chlamydia Trachomatis Conjunctivitis |
5-12d after birth; silver nitrate ophthalmic only rx gonorrhea |
Erythromycin base 50mg/kg/day PO / 4 doses x14days |
|||
|
Chlamydia Trachomatis Pneumonia |
1-3months; afebrile, staccato cough with diffuse infiltrates on CXR; peripheral eosinophilia |
Erythromycin base 50mg/kg/day po / 4 doses x14days |
|||
|
Trichamonas vaginalis |
White, thick discharge |
Metronidazole 2g po x 1 OR Tinidazole 2g po x 1 PLUS Azithro 1g po x 1 -intravag cream not recommended |
Metronidazole 500mg bid for 7days; 1-2g po qday x 7d if recurrence OR Topical clotrimazole for metronidazole allergy– not as effective |
Metronidazole 2g po x 1 |
Rx only if symptomatic but rx partner 1st trimester, Clotrimazole 100mg hs for 7days After 1st trimester, Metronidazole 2g po x 1 |
|
Bacterial Vaginosis Lactobacillus |
White, fishy discharge |
Metronidazole 500mg po bid for 7d OR 0.75% Metronidazole gel (one full applicator 5g) intravaginal qd for 5d OR 2% Clindamycin cream 5g qd for 5d |
Clindamycin 300mg po bid for 7d (recurrence) OR Clindamycin ovules 100mg intravaginally qhs x 3d |
Exam for STD No rx if nl |
1st trimester, metronidazole 250mg po tid x7d After 1st trimester, 500mg po bid for 7days or 250mg po tid x7d or Clinda 300mg po bid x 7d |
|
Candidiasis (Candida albicans) |
Cottage cheese; DM or immunocompromised |
Butoconazole 2% cream 5g intravaginally for 3d OR Butaconazole-sustained 2% intravag x1 |
Clotrimazole 1% 5g cream intravaginally for 7-14d (OTC) OR Clotrimazole 100mg intravag tablet x 7d |
Candicidal cream if dermatitis present |
Avoid fluconazole and ketoconazole. Rx with cream for 7d |
|
Chancroid (H. ducreyi) |
Painful ulcers with suppurative LAD |
Azithromycin 1g PO x 1 |
CTX 250mg IM x1 Cipro 500mg PO bid x 3days |
See CDC |
CTX |
|
Granuloma Inguinale (Donvanosis) Klebsiella granulomatis |
Painless lesions without LAD |
Doxycycline 100mg PO BID x 3wks and until all lesions heald |
Aizthromycin 1g po q week Ciproflox 750mg PO bid x 3 weeks Bactrim DS 1tab PO BID x 3 wks |
same |
Erythromycin base 500mg po qid x 3wks |
|
Lymphogranuloma Venereum (LGV) C. trach serovars L1-L3 |
Tender, unilateral LAD; can lead to proctitis, fistulas |
Doxycycline 100mg po bid x 3 weeks |
Erythromycin base 500mg po qid x 3wks |
Treat within 60days of exposure with standard Chlamydia Rx |
Erythromycin base 500mg po qid x 3wks |
|
Chancre- Primary Syphilis (T. pallidum) |
Painless ulcer, chancre |
Benzathine Penicillin G 1.2million U IM x1 |
Doxycycline 100mg po bid x 14d Tetracycline 500mg po qid x 14d CTX 1g IM/IV x 8-10d Azithromycin 2g po x 1? |
See CDC |
Penicillin; if allergic desensitize |
|
Secondary Syphilis (T. pallidum) |
Skin rash, mucocutaneous lesions, LAD |
See CDC |
|||
|
Latent Syphilis |
Seroreactivity without other evidence of disease |
Early: Benzathine Penicillin G 2.4 million U IM x1 Late: Benzathine Penicillin G 2.4million U IM qweek x 3 |
Doxycycline 100mg po bid x 28d Tetracycline 500mg po qid x 28d |
See CDC |
|
|
Tertiary Syphilis (T. pallidum) |
Cardiac (aortitis), ophtho (iritis, uveitis), gumma |
Benzathine Penicillin G 2.4million U IM qweek x 3 |
See CDC |
||
|
Neurosyphilis |
Meningitis, syphilitic eye disease |
Aqueous crystalline penicillin G 18-24million units/d administered as 3-4million units IV q4h or continuous infusion x 10-14days |
Procaine penicillin 2.4million units IM qday + Probenecid 500mg po qid BOTH for 10-14d |
||
|
HSV (1st episode) |
Vesilcular rash |
Acyclovir 400mg po TID x 7-10day |
Famciclovir 250mg po TID x 7-10d Valacyclovir 1g PO BID x 7-10d |
||
|
HSV (suppressive) |
Acyclovir 400mg PO BID |
Famciclovir 250mg po BID Valacyclovir 500mg PO qday |
|||
|
Epididymitis |
Pain, swelling, inflammation of the epididymis |
CTX 250mg IM + Doxycyline 100mg po bid x 10d |
Oflox 300mg po bid x 10d + levoflox 500mg po qday x 10d |
||
|
Epididymorchitis |
|||||
|
Proctitis |
Inflammation of the rectum (distal 10-12cm) |
CTX 125mg IM x1 + Doxy 100mg po bid x 7d |
|||
|
PID |
Sexually active, no other sources and: CMT OR uterine OR adnexal TTP |
Outpt: Ceftriaxone 250mg IM x1 OR Cefoxitin 2g IM in a single dose and probenecid 1g orally administered concurrently in single dose OR Other parenteral 3rd gen cephalosporin eg ceftizoxime or cefotaxime PLUS Doxy 100mg po bid x14d +/- Metronidazole 500mg po bid x 14d Parenteral: Cefotetan 2g IV q12h OR Cefoxitin 2g IV q6h PLUS Doxycyline 100mg IV or PO q12 (similar bioavailability) |
Outpt: Oflox 400mg po bid x 14d OR Levofloxacin 500mg po qday x 14d +/- Metronidazole 500mg po bid x 14d Parenteral: Clinda 900mg IV q8h PLUS Gent load 2mgkg IV; maintenance 1.5mg/kg q8h; single daily dosing may be substituted Oflox 400mg IV q12h OR Levoflox 500mg IV qday +/- Metro 500mg IVq8h OR Unasyn 3g IV q6h PLUS Doxy 100mg IV or PO q12h |
||
|
Scabies |
Crusted rash, intertiginous areas |
Permethrin 5% cream applied to all areas of body from neck down and rinsed off after 8-14h |
Ivermectin 200mcg/kg PO, repeated in 2weeks Lindane (1%) 1 ounce of lotion of 30g of cream applied in thin layer all over from neck down x 8 hours then rinse |
||
|
Pediculosis Pubis |
Puritic genitalia |
Permethrin 1% cream: apply to affected areas x 10mins then wash off |
Malathion lotion 0.5% apply x 8-12h then rinse OR Ivermectin 250mcg/kg PO repeated in 2 weeks |
*BV: in pregnancy, associated with premature rupture of membranes, chorioamnionitis, preterm birth, postpartum infxn
†Test for HIV, syphilis
DeBonis
Adapted from CDC 2006
Disorder
Clinical
1st line
Alternative
Partner
In Pregnancy
N. Gonorrhea
Urethritis/
Cervicitis
M: urethritis with d/c or simply dysuria;can be asymptomatic
F: purulent discharge; can be asymptomatic
Ceftriaxone 125mg IM
OR
Cefixime (Suprax) 400mg po x1
Cipro 500po x 1 – not acceptable in MSM, travel, California, Hawaii
OR
Spectinomycin 2g IM x 1 OR
Azithromycin 2g po x 1
Treat and abstinence x 7d after both treated
CTX 125mg IM x 1
N. Gonorrhea
Conjunctivitis
2-5d after birth
Erythromycin ophthalmic 0.5% x1
Tetracycline ophthalmic 1% x1
N. Gonorrhea
Disseminated
(DGI)
Petechial, pustular acral skin lesions,
Asymmetrical arthralgias, tenosynovitis,
Septic arthritis
CTX 1g IM/IV q24
-continue x24-48h until improvement
Cefotax 1g IV q8
Spectinomycin 2g IV q12
Chlamydia Trachomatis
M: urethritis with d/c or simply dysuria; can be asymptomatic
F: purulent discharge or cervical bleeding; can be asymptomatic
Azithromycin 1g po x1
OR
Doxycycline 100mg po bid x 7d
Erythromycin base 500mg po qid x 7d OR
Oflox 300mg po bid x 7d
OR
Levoflox 500mg po qd x 7days
Treat and abstinence x 7d after both treated
Azithromycin 1g po x1 or
Amoxicillin 500mg po tid x 7d
Or
Erythro
Chlamydia
Trachomatis
Conjunctivitis
5-12d after birth; silver nitrate ophthalmic only rx gonorrhea
Erythromycin base 50mg/kg/day PO / 4 doses x14days
Chlamydia Trachomatis
Pneumonia
1-3months; afebrile, staccato cough with diffuse infiltrates on CXR; peripheral eosinophilia
Erythromycin base 50mg/kg/day po / 4 doses x14days
Trichamonas vaginalis
White, thick discharge
Metronidazole 2g po x 1
OR
Tinidazole 2g po x 1
PLUS
Azithro 1g po x 1
-intravag cream not recommended
Metronidazole 500mg bid for 7days; 1-2g po qday x 7d if recurrence
OR
Topical clotrimazole for metronidazole allergy– not as effective
Metronidazole 2g po x 1
Rx only if symptomatic but rx partner
1st trimester, Clotrimazole 100mg hs for 7days
After 1st trimester, Metronidazole 2g po x 1
Bacterial Vaginosis
Lactobacillus
White, fishy discharge
Metronidazole 500mg po bid for 7d
OR
0.75% Metronidazole gel (one full applicator 5g) intravaginal qd for 5d
OR
2% Clindamycin cream 5g qd for 5d
Clindamycin 300mg po bid for 7d (recurrence)
OR
Clindamycin ovules 100mg intravaginally qhs x 3d
Exam for STD
No rx if nl
1st trimester, metronidazole 250mg po tid x7d
After 1st trimester, 500mg po bid for 7days or 250mg po tid x7d or Clinda 300mg po bid x 7d
Candidiasis
(Candida albicans)
Cottage cheese;
DM or immunocompromised
Butoconazole 2% cream 5g intravaginally for 3d
OR
Butaconazole-sustained 2% intravag x1
Clotrimazole 1% 5g cream intravaginally for 7-14d (OTC)
OR
Clotrimazole 100mg intravag tablet x 7d
Candicidal cream if dermatitis present
Avoid fluconazole and ketoconazole.
Rx with cream for 7d
Chancroid
(H. ducreyi)
Painful ulcers with suppurative LAD
Azithromycin 1g PO x 1
CTX 250mg IM x1
Cipro 500mg PO bid x 3days
See CDC
CTX
Granuloma Inguinale (Donvanosis)
Klebsiella granulomatis
Painless lesions without LAD
Doxycycline 100mg PO BID x 3wks and until all lesions heald
Aizthromycin 1g po q week
Ciproflox 750mg PO bid x 3 weeks
Bactrim DS 1tab PO BID x 3 wks
same
Erythromycin base 500mg po qid x 3wks
Lymphogranuloma Venereum (LGV)
C. trach serovars L1-L3
Tender, unilateral LAD; can lead to proctitis, fistulas
Doxycycline 100mg po bid x 3 weeks
Erythromycin base 500mg po qid x 3wks
Treat within 60days of exposure with standard Chlamydia Rx
Erythromycin base 500mg po qid x 3wks
Chancre-
Primary
Syphilis
(T. pallidum)
Painless ulcer, chancre
Benzathine Penicillin G 1.2million U IM x1
Doxycycline 100mg po bid x 14d
Tetracycline 500mg po qid x 14d
CTX 1g IM/IV x 8-10d
Azithromycin 2g po x 1?
See CDC
Penicillin; if allergic desensitize
Secondary Syphilis
(T. pallidum)
Skin rash, mucocutaneous lesions, LAD
See CDC
Latent Syphilis
Seroreactivity without other evidence of disease
Early: Benzathine Penicillin G 2.4 million U IM x1
Late: Benzathine Penicillin G 2.4million U IM qweek x 3
Doxycycline 100mg po bid x 28d
Tetracycline 500mg po qid x 28d
See CDC
Tertiary Syphilis
(T. pallidum)
Cardiac (aortitis), ophtho (iritis, uveitis), gumma
Benzathine Penicillin G 2.4million U IM qweek x 3
See CDC
Neurosyphilis
Meningitis, syphilitic eye disease
Aqueous crystalline penicillin G 18-24million units/d administered as 3-4million units IV q4h or continuous infusion x 10-14days
Procaine penicillin 2.4million units IM qday + Probenecid 500mg po qid
BOTH for 10-14d
HSV (1st episode)
Vesilcular rash
Acyclovir 400mg po TID x 7-10day
Famciclovir 250mg po TID x 7-10d
Valacyclovir 1g PO BID x 7-10d
HSV (suppressive)
Acyclovir 400mg PO BID
Famciclovir 250mg po BID
Valacyclovir 500mg PO qday
Epididymitis
Pain, swelling, inflammation of the epididymis
CTX 250mg IM + Doxycyline 100mg po bid x 10d
Oflox 300mg po bid x 10d + levoflox 500mg po qday x 10d
Epididymorchitis
Proctitis
Inflammation of the rectum (distal 10-12cm)
CTX 125mg IM x1 + Doxy 100mg po bid x 7d
PID
Sexually active, no other sources and: CMT OR uterine OR adnexal TTP
Outpt:
Ceftriaxone 250mg IM x1
OR
Cefoxitin 2g IM in a single dose and probenecid 1g orally administered concurrently in single dose
OR
Other parenteral 3rd gen cephalosporin eg ceftizoxime or cefotaxime
PLUS
Doxy 100mg po bid x14d
+/-
Metronidazole 500mg po bid x 14d
Parenteral:
Cefotetan 2g IV q12h
OR
Cefoxitin 2g IV q6h
PLUS
Doxycyline 100mg IV or PO q12
(similar bioavailability)
Outpt:
Oflox 400mg po bid x 14d
OR
Levofloxacin 500mg po qday x 14d
+/-
Metronidazole 500mg po bid x 14d
Parenteral:
Clinda 900mg IV q8h
PLUS
Gent load 2mgkg IV; maintenance 1.5mg/kg q8h; single daily dosing may be substituted
Oflox 400mg IV q12h
OR
Levoflox 500mg IV qday
+/-
Metro 500mg IVq8h
OR
Unasyn 3g IV q6h
PLUS
Doxy 100mg IV or PO q12h
Scabies
Crusted rash, intertiginous areas
Permethrin 5% cream applied to all areas of body from neck down and rinsed off after 8-14h
Ivermectin 200mcg/kg PO, repeated in 2weeks
Lindane (1%) 1 ounce of lotion of 30g of cream applied in thin layer all over from neck down x 8 hours then rinse
Pediculosis Pubis
Puritic genitalia
Permethrin 1% cream: apply to affected areas x 10mins then wash off
Malathion lotion 0.5% apply x 8-12h then rinse
OR
Ivermectin 250mcg/kg PO repeated in 2 weeks
- BV: in pregnancy, associated with premature rupture of membranes, chorioamnionitis, preterm birth, postpartum infxn
†Test for HIV, syphilis
DeBonis
Adapted from CDC 2006
